Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel Bilbao is active.

Publication


Featured researches published by Daniel Bilbao.


Nature | 1999

Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.

Livia Merendino; Sabine Guth; Daniel Bilbao; Concepción Martínez; Juan Valcárcel

The protein Sex-lethal (SXL) controls dosage compensation in Drosophila by inhibiting the splicing and translation of male-specific-lethal-2 (msl-2) transcripts. Here we report that splicing inhibition of msl-2 requires a binding site for SXL at the polypyrimidine (poly(Y)) tract associated with the 3′ splice site, and an unusually long distance between the poly(Y) tract and the conserved AG dinucleotide at the 3′ end of the intron. Only this combination allows efficient blockage of U2 small nuclear ribonucleoprotein particle binding and displacement of the large subunit of the U2 auxiliary factor (U2AF65) from the poly(Y) tract by SXL. Crosslinking experiments with ultraviolet light indicate that the small subunit of U2AF (U2AF35) contacts the AG dinucleotide only when located in proximity to the poly(Y) tract. This interaction stabilizes U2AF65 binding such that SXL can no longer displace it from the poly(Y) tract. Our results reveal a novel function for U2AF35, a critical role for the 3′ splice site AG at the earliest steps of spliceosome assembly and the need for a weakened U2AF35–AG interaction to regulate intron removal.


Cancer Cell | 2009

Hematopoietic Stem Cell Expansion Precedes the Generation of Committed Myeloid Leukemia-Initiating Cells in C/EBPα Mutant AML

Oxana Bereshchenko; Elena Mancini; Susan Moore; Daniel Bilbao; Robert Månsson; Sidinh Luc; Amit Grover; Sten Eirik W. Jacobsen; David Bryder; Claus Nerlov

We here use knockin mutagenesis in the mouse to model the spectrum of acquired CEBPA mutations in human acute myeloid leukemia. We find that C-terminal C/EBPalpha mutations increase the proliferation of long-term hematopoietic stem cells (LT-HSCs) in a cell-intrinsic manner and override normal HSC homeostasis, leading to expansion of premalignant HSCs. However, such mutations impair myeloid programming of HSCs and block myeloid lineage commitment when homozygous. In contrast, N-terminal C/EBPalpha mutations are silent with regards to HSC expansion, but allow the formation of committed myeloid progenitors, the templates for leukemia-initiating cells. The combination of N- and C-terminal C/EBPalpha mutations incorporates both features, accelerating disease development and explaining the clinical prevalence of this configuration of CEBPA mutations.


Molecular Therapy | 2015

Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.

Joanne Tonkin; Lieve Temmerman; Robert D. Sampson; Enrique Gallego-Colon; Laura Barberi; Daniel Bilbao; Michael D. Schneider; Antonio Musarò; Nadia Rosenthal

Insulin-like growth factor 1 (IGF-1) is a potent enhancer of tissue regeneration, and its overexpression in muscle injury leads to hastened resolution of the inflammatory phase. Here, we show that monocytes/macrophages constitute an important initial source of IGF-1 in muscle injury, as conditional deletion of the IGF-1 gene specifically in mouse myeloid cells (ϕIGF-1 CKO) blocked the normal surge of local IGF-1 in damaged muscle and significantly compromised regeneration. In injured muscle, Ly6C+ monocytes/macrophages and CD206+ macrophages expressed equivalent IGF-1 levels, which were transiently upregulated during transition from the inflammation to repair. In injured ϕIGF-1 CKO mouse muscle, accumulation of CD206+ macrophages was impaired, while an increase in Ly6C+ monocytes/macrophages was favored. Transcriptional profiling uncovered inflammatory skewing in ϕIGF-1 CKO macrophages, which failed to fully induce a reparative gene program in vitro or in vivo, revealing a novel autocrine role for IGF-1 in modulating murine macrophage phenotypes. These data establish local macrophage-derived IGF-1 as a key factor in inflammation resolution and macrophage polarization during muscle regeneration.


The EMBO Journal | 2012

FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors

Elena Mancini; Alejandra Sanjuan-Pla; Luisa Luciani; Susan Hardman Moore; Amit Grover; Agnes Zay; Kasper D. Rasmussen; Sidinh Luc; Daniel Bilbao; Dónal O'Carroll; Sten Eirik W. Jacobsen; Claus Nerlov

The transcription factors that control lineage specification of haematopoietic stem cells (HSCs) have been well described for the myeloid and lymphoid lineages, whereas transcriptional control of erythroid (E) and megakaryocytic (Mk) fate is less understood. We here use conditional removal of the GATA‐1 and FOG‐1 transcription factors to identify FOG‐1 as required for the formation of all committed Mk‐ and E‐lineage progenitors, whereas GATA‐1 was observed to be specifically required for E‐lineage commitment. FOG‐1‐deficient HSCs and preMegEs, the latter normally bipotent for the Mk and E lineages, underwent myeloid transcriptional reprogramming, and formed myeloid, but not erythroid and megakaryocytic cells in vitro. These results identify FOG‐1 and GATA‐1 as required for formation of bipotent Mk/E progenitors and their E‐lineage commitment, respectively, and show that FOG‐1 mediates transcriptional Mk/E programming of HSCs as well as their subsequent Mk/E‐lineage commitment. Finally, C/EBPs and FOG‐1 exhibited transcriptional cross‐regulation in early myelo‐erythroid progenitors making their functional antagonism a potential mechanism for separation of the myeloid and Mk/E lineages.


American Journal of Pathology | 2008

Overexpression of mIGF-1 in Keratinocytes Improves Wound Healing and Accelerates Hair Follicle Formation and Cycling in Mice

Ekaterina Semenova; Heidi Koegel; Sybille Hasse; Jennifer E. Klatte; Esfir Slonimsky; Daniel Bilbao; Ralf Paus; Sabine Werner; Nadia Rosenthal

Insulin-like growth factor 1 (IGF-1) is an important regulator of growth, survival, and differentiation in many tissues. It is produced in several isoforms that differ in their N-terminal signal peptide and C-terminal extension peptide. The locally acting isoform of IGF-1 (mIGF-1) was previously shown to enhance the regeneration of both muscle and heart. In this study, we tested the therapeutic potential of mIGF-1 in the skin by generating a transgenic mouse model in which mIGF-1 expression is driven by the keratin 14 promoter. IGF-1 levels were unchanged in the sera of hemizygous K14/mIGF-1 transgenic animals whose growth was unaffected. A skin analysis of young animals revealed normal architecture and thickness as well as proper expression of differentiation and proliferation markers. No malignant tumors were formed. Normal homeostasis of the putative stem cell compartment was also maintained. Healing of full-thickness excisional wounds was accelerated because of increased proliferation and migration of keratinocytes, whereas inflammation, granulation tissue formation, and scarring were not obviously affected. In addition, mIGF-1 promoted late hair follicle morphogenesis and cycling. To our knowledge, this is the first work to characterize the simultaneous, stimulatory effect of IGF-1 delivery to keratinocytes on two types of regeneration processes within a single mouse model. Our analysis supports the use of mIGF-1 for skin and hair regeneration and describes a potential cell type-restricted action.


Embo Molecular Medicine | 2014

Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease.

Daniel Bilbao; Luisa Luciani; Bjarki Johannesson; Agnieszka Piszczek; Nadia Rosenthal

The recent precipitous rise in autoimmune diseases is placing an increasing clinical and economic burden on health systems worldwide. Current therapies are only moderately efficacious, often coupled with adverse side effects. Here, we show that recombinant human insulin‐like growth factor‐1 (rhIGF‐1) stimulates proliferation of both human and mouse regulatory T (Treg) cells in vitro and when delivered systemically via continuous minipump, it halts autoimmune disease progression in mouse models of type 1 diabetes (STZ and NOD) and multiple sclerosis (EAE) in vivo. rhIGF‐1 administration increased Treg cells in affected tissues, maintaining their suppressive properties. Genetically, ablation of the IGF‐1 receptor specifically on Treg cell populations abrogated the beneficial effects of rhIGF‐1 administration on the progression of multiple sclerotic symptoms in the EAE model, establishing a direct effect of IGF‐1 on Treg cell proliferation. These results establish systemically delivered rhIGF‐1 as a specific, effective stimulator of Treg cell action, underscoring the clinical feasibility of manipulating natural tolerance mechanisms to suppress autoimmune disease.


Nature Methods | 2015

Genetic targeting of chemical indicators in vivo

Guoying Yang; Fernanda de Castro Reis; Mayya Sundukova; Sofia Pimpinella; Antonino Asaro; Laura Castaldi; Laura Batti; Daniel Bilbao; Luc Reymond; Kai Johnsson; Paul A. Heppenstall

Fluorescent protein reporters have become the mainstay for tracing cellular circuitry in vivo but are limited in their versatility. Here we generated Cre-dependent reporter mice expressing the Snap-tag to target synthetic indicators to cells. Snap-tag labeling worked efficiently and selectively in vivo, allowing for both the manipulation of behavior and monitoring of cellular fluorescence from the same reporter.


Open Biology | 2012

Regulation of ASIC channels by a stomatin/STOML3 complex located in a mobile vesicle pool in sensory neurons

Liudmila Lapatsina; Julia A. Jira; Ewan St. John Smith; Kate Poole; Alexey Kozlenkov; Daniel Bilbao; Gary R. Lewin; Paul A. Heppenstall

A complex of stomatin-family proteins and acid-sensing (proton-gated) ion channel (ASIC) family members participate in sensory transduction in invertebrates and vertebrates. Here, we have examined the role of the stomatin-family protein stomatin-like protein-3 (STOML3) in this process. We demonstrate that STOML3 interacts with stomatin and ASIC subunits and that this occurs in a highly mobile vesicle pool in dorsal root ganglia (DRG) neurons and Chinese hamster ovary cells. We identify a hydrophobic region in the N-terminus of STOML3 that is required for vesicular localization of STOML3 and regulates physical and functional interaction with ASICs. We further characterize STOML3-containing vesicles in DRG neurons and show that they are Rab11-positive, but not part of the early-endosomal, lysosomal or Rab14-dependent biosynthetic compartment. Moreover, uncoupling of vesicles from microtubules leads to incorporation of STOML3 into the plasma membrane and increased acid-gated currents. Thus, STOML3 defines a vesicle pool in which it associates with molecules that have critical roles in sensory transduction. We suggest that the molecular features of this vesicular pool may be characteristic of a ‘transducosome’ in sensory neurons.


Disease Models & Mechanisms | 2014

Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice

Bjarki Johannesson; Susanne Sattler; Ekaterina Semenova; Saveria Pastore; Teresa Kennedy-Lydon; Robert D. Sampson; Michael D. Schneider; Nadia Rosenthal; Daniel Bilbao

Allergic contact dermatitis (ACD) is triggered by an aberrant hyperinflammatory immune response to innocuous chemical compounds and ranks as the world’s most prevalent occupational skin condition. Although a variety of immune effector cells are activated during ACD, regulatory T (Treg) cells are crucial in controlling the resulting inflammation. Insulin-like growth factor-1 (IGF-1) regulates cell proliferation and differentiation and accelerates wound healing and regeneration in several organs including the skin. Recently IGF-1 has also been implicated in protection from autoimmune inflammation by expansion of Treg cells. Here, we demonstrate that ectopic expression of IGF-1 in mouse skin suppresses ACD in a Treg cell-specific manner, increasing the number of Foxp3+ Treg cells in the affected area and stimulating lymphocyte production of the anti-inflammatory cytokine interleukin 10. Similar therapeutic effects can be achieved with systemic or topical delivery of IGF-1, implicating this growth factor as a promising new therapeutic option for the treatment of ACD.


EMBO Reports | 2016

A subpopulation of itch-sensing neurons marked by Ret and somatostatin expression

Kalina K Stantcheva; Loredana Iovino; Rahul Dhandapani; Concepcion Martinez; Laura Castaldi; Linda Nocchi; Emerald Perlas; Carla Portulano; Martina Pesaresi; Kalyanee Shirlekar; Fernanda de Castro Reis; Triantafillos Paparountas; Daniel Bilbao; Paul A. Heppenstall

Itch, the unpleasant sensation that elicits a desire to scratch, is mediated by specific subtypes of cutaneous sensory neuron. Here, we identify a subpopulation of itch‐sensing neurons based on their expression of the receptor tyrosine kinase Ret. We apply flow cytometry to isolate Ret‐positive neurons from dorsal root ganglia and detected a distinct population marked by low levels of Ret and absence of isolectin B4 binding. We determine the transcriptional profile of these neurons and demonstrate that they express neuropeptides such as somatostatin (Sst), the NGF receptor TrkA, and multiple transcripts associated with itch. We validate the selective expression of Sst using an Sst‐Cre driver line and ablated these neurons by generating mice in which the diphtheria toxin receptor is conditionally expressed from the sensory neuron‐specific Avil locus. Sst‐Cre::AviliDTR mice display normal nociceptive responses to thermal and mechanical stimuli. However, scratching behavior evoked by interleukin‐31 (IL‐31) or agonist at the 5HT1F receptor is significantly reduced. Our data provide a molecular signature for a subpopulation of neurons activated by multiple pruritogens.

Collaboration


Dive into the Daniel Bilbao's collaboration.

Top Co-Authors

Avatar

Nadia Rosenthal

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paul A. Heppenstall

European Bioinformatics Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael D. Schneider

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert D. Sampson

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amit Grover

European Bioinformatics Institute

View shared research outputs
Top Co-Authors

Avatar

Bjarki Johannesson

European Bioinformatics Institute

View shared research outputs
Top Co-Authors

Avatar

Claus Nerlov

European Bioinformatics Institute

View shared research outputs
Top Co-Authors

Avatar

Ekaterina Semenova

European Bioinformatics Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge